Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
18.71
Dollar change
-0.32
Percentage change
-1.68
%
IndexRUT P/E- EPS (ttm)-1.44 Insider Own6.67% Shs Outstand39.17M Perf Week-1.37%
Market Cap732.87M Forward P/E- EPS next Y-1.30 Insider Trans-0.78% Shs Float36.56M Perf Month6.98%
Income-55.74M PEG- EPS next Q-0.40 Inst Own104.57% Short Float10.18% Perf Quarter51.99%
Sales177.13M P/S4.14 EPS this Y3.26% Inst Trans-0.57% Short Ratio4.25 Perf Half Y19.32%
Book/sh3.86 P/B4.85 EPS next Y6.75% ROA-20.84% Short Interest3.72M Perf Year-51.59%
Cash/sh4.63 P/C4.04 EPS next 5Y16.20% ROE-35.39% 52W Range6.08 - 46.57 Perf YTD52.49%
Dividend Est.0.13 (0.68%) P/FCF- EPS past 5Y-3.21% ROI-23.81% 52W High-59.82% Beta1.48
Dividend TTM- Quick Ratio6.97 Sales past 5Y40.27% Gross Margin71.75% 52W Low207.73% ATR (14)0.97
Dividend Ex-Date- Current Ratio7.95 EPS Y/Y TTM6.80% Oper. Margin-33.46% RSI (14)62.05 Volatility4.48% 6.60%
Employees474 Debt/Eq0.56 Sales Y/Y TTM27.77% Profit Margin-31.47% Recom2.30 Target Price20.00
Option/ShortYes / Yes LT Debt/Eq0.55 EPS Q/Q0.66% Payout- Rel Volume0.51 Prev Close19.03
Sales Surprise12.73% EPS Surprise21.56% Sales Q/Q17.97% EarningsFeb 28 AMC Avg Volume874.84K Price18.71
SMA208.85% SMA5014.25% SMA20012.60% Trades Volume518,252 Change-1.68%
Date Action Analyst Rating Change Price Target Change
Mar-07-24Upgrade Argus Hold → Buy $24
Jan-19-24Upgrade Stifel Hold → Buy $9 → $20
Jan-03-24Initiated Lake Street Buy $20
Oct-24-23Upgrade Wolfe Research Underperform → Peer Perform
Oct-11-23Downgrade Stifel Buy → Hold $45 → $12
Oct-11-23Downgrade CL King Buy → Neutral
Oct-11-23Downgrade Citigroup Buy → Sell $35 → $8
Oct-11-23Downgrade B. Riley Securities Buy → Neutral $54 → $14
Sep-21-23Downgrade Argus Buy → Hold
Sep-06-23Initiated Oppenheimer Outperform $30
Mar-22-24 12:00PM
Mar-07-24 09:00PM
07:52AM
Mar-05-24 09:00AM
Feb-29-24 10:50AM
06:38AM Loading…
06:38AM
Feb-28-24 06:20PM
05:18PM
04:40PM
04:05PM
Feb-07-24 04:30PM
Jan-22-24 07:27AM
Dec-26-23 04:40AM
Dec-21-23 11:08PM
Dec-20-23 04:30PM
04:09AM Loading…
Dec-08-23 04:09AM
Nov-21-23 05:56PM
Nov-13-23 04:07PM
Nov-10-23 01:19PM
Nov-09-23 01:50AM
Nov-08-23 06:42PM
05:05PM
04:05PM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 02:02PM
Oct-26-23 04:30PM
Oct-25-23 10:25AM
Oct-16-23 11:29AM
Oct-11-23 06:16PM
12:07PM Loading…
12:07PM
12:06PM
11:30AM
11:01AM
08:08AM
03:49AM
Oct-10-23 04:20PM
04:20PM
Sep-21-23 10:06AM
Sep-04-23 04:30PM
Aug-11-23 06:19AM
Aug-03-23 04:30PM
Aug-02-23 10:21AM
09:03AM
Aug-01-23 05:35PM
04:30PM
04:05PM
Jul-13-23 02:25AM
Jul-12-23 12:35PM
08:57AM
Jul-11-23 04:30PM
Jun-30-23 08:31AM
May-22-23 07:09AM
06:54AM
May-16-23 03:28AM
May-09-23 06:25PM
05:18PM
04:05PM
May-07-23 08:54AM
May-05-23 09:00AM
May-04-23 04:30PM
Apr-26-23 04:30PM
Apr-18-23 04:30PM
Mar-31-23 10:36AM
08:11AM
Mar-27-23 09:54AM
Mar-02-23 08:29PM
Mar-01-23 07:52AM
Feb-28-23 08:05PM
04:05PM
Feb-07-23 09:00AM
Jan-23-23 12:00PM
Jan-09-23 07:20AM
07:05AM
Dec-30-22 12:46AM
Dec-28-22 04:30PM
Dec-22-22 11:47AM
Dec-12-22 09:15AM
Dec-05-22 12:00PM
Nov-10-22 07:36AM
Nov-08-22 07:35PM
04:05PM
Nov-03-22 04:30PM
Nov-01-22 12:35PM
Oct-25-22 04:30PM
Oct-19-22 01:27PM
Oct-18-22 07:46PM
Oct-17-22 08:03PM
04:25PM
12:53PM
Sep-29-22 07:41AM
Sep-28-22 02:25PM
Sep-07-22 04:15PM
Aug-30-22 04:15PM
Jul-27-22 09:31AM
Jul-26-22 05:35PM
04:05PM
Jul-22-22 01:26PM
Jul-12-22 04:15PM
07:07AM
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ballinger Kevin J.DirectorMar 05 '24Buy16.9911,700198,78317,807Mar 07 06:01 AM
Buchanan Lucas W.COO/CFOMar 05 '24Sale17.179,877169,578500,925Mar 05 07:51 PM
Davis Andrew S.Chief Commercial OfficerMar 05 '24Sale17.175,48194,103287,773Mar 05 06:25 PM
Ruedy RichardEVPClin&Reg.Affairs&QAMar 05 '24Sale17.173,80065,242205,711Mar 05 07:50 PM
Jones Marie L.VP, Finance and CAOMar 05 '24Sale17.172,60244,67476,894Mar 05 06:20 PM
Klemz Kevin MEVP/Chief Legal Officer/Sec.Mar 05 '24Sale17.172,49742,871165,194Mar 05 06:16 PM
Ruedy RichardEVPClin&Reg.Affairs&QAFeb 29 '24Sale22.253,00066,750170,837Mar 04 06:19 PM
Jones Marie L.CAO and VP, FinanceOct 27 '23Sale6.616564,33454,941Oct 30 06:53 PM
Buchanan Lucas W.COO/CFOOct 04 '23Sale15.222,66240,524435,848Oct 06 06:28 PM
Klemz Kevin MEVP/Chief Legal Officer/Sec.Aug 17 '23Sale20.111,53930,94238,797Aug 18 08:16 PM
Davis Andrew S.Chief Commercial OfficerAug 03 '23Sale22.136,587145,797109,534Aug 04 05:31 PM
Buchanan Lucas W.COO/CFOJul 28 '23Option Exercise5.429,64352,229215,725Jul 31 05:44 PM
Jones Marie L.CAO and VP, FinanceJul 20 '23Option Exercise6.112,00012,22048,002Jul 21 06:24 PM
Rogers Erica J.President and CEOJul 11 '23Option Exercise1.601,0001,600270,639Jul 13 06:34 PM
Rogers Erica J.President and CEOJul 11 '23Sale31.561,00031,560269,639Jul 13 06:34 PM
Davis Andrew S.Chief Commercial OfficerJul 06 '23Sale30.79692,124115,614Jul 10 05:39 PM
Rogers Erica J.President and CEOJun 12 '23Option Exercise1.601,0001,600270,639Jun 13 08:13 PM
Rogers Erica J.President and CEOJun 12 '23Sale32.131,00032,130269,639Jun 13 08:13 PM
Rogers Erica J.President and CEOMay 11 '23Option Exercise1.603,0004,800272,132May 12 09:37 PM
Rogers Erica J.President and CEOMay 11 '23Sale35.513,000106,530269,132May 12 09:37 PM
Davis Andrew S.Chief Commercial OfficerMay 01 '23Option Exercise5.906,75339,845122,436May 03 06:39 PM
Davis Andrew S.Chief Commercial OfficerMay 01 '23Sale44.516,753300,593115,683May 03 06:39 PM
WEATHERMAN ELIZABETH HDirectorApr 17 '23Sale41.915,000209,550144,454Apr 19 06:14 PM
Rogers Erica J.President and CEOApr 11 '23Option Exercise1.606,0009,600275,132Apr 12 05:29 PM
Rogers Erica J.President and CEOApr 11 '23Sale39.776,000238,635269,132Apr 12 05:29 PM
Davis Andrew S.Chief Commercial OfficerApr 03 '23Option Exercise4.796,75332,372122,436Apr 05 05:19 PM
Davis Andrew S.Chief Commercial OfficerApr 03 '23Sale39.426,753266,203115,683Apr 05 05:19 PM